GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (XTER:NOV) » Definitions » Gross Loan

Novo Nordisk A/S (XTER:NOV) Gross Loan


View and export this data going back to 1999. Start your Free Trial

What is Novo Nordisk A/S Gross Loan?

Gross Loan only applies to banks.


Novo Nordisk A/S (XTER:NOV) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.